Harbert

Dinsmore & Shohl Adds Second Office in Florida in Merger with Orlando's Mateer & Harbert

Retrieved on: 
Tuesday, August 1, 2023
State, Private law, Harbert, Foot, Risk management, Sunlight, Dinsmore & Shohl, Student, Sunshine State, Growth, Environment, Retail, Property management, Central Florida

ORLANDO, Fla., Aug. 1, 2023 /PRNewswire-PRWeb/ -- National law firm Dinsmore & Shohl LLP is excited to announce that only three years after its first expansion into Florida, the Firm is growing again through a merger with the highly regarded Mateer & Harbert. With the addition of Mateer's 19 attorneys and nearly two dozen business professionals in the Florida region, Dinsmore expands its office count to 30 and builds on the footprint established in Tampa in 2020. With its foot on the accelerator, Dinsmore is executing on its strategy to identify opportunities that meet client needs and grow the Firm under the leadership of Joshua Lorentz, who took over as managing partner in January 2023.

Key Points: 
  • National law firm Dinsmore & Shohl LLP is excited to announce that only three years after its first expansion into Florida, the Firm is growing again through a merger with the highly regarded Mateer & Harbert.
  • ORLANDO, Fla., Aug. 1, 2023 /PRNewswire-PRWeb/ -- National law firm Dinsmore & Shohl LLP is excited to announce that only three years after its first expansion into Florida, the Firm is growing again through a merger with the highly regarded Mateer & Harbert.
  • With the addition of Mateer's 19 attorneys and nearly two dozen business professionals in the Florida region, Dinsmore expands its office count to 30 and builds on the footprint established in Tampa in 2020.
  • "Like Mateer & Harbert, Dinsmore is a well-established firm that has been around for a long time," Tom Harbert said.

Dolphin Seeks Qumu Strategic Sale—Immediate Break-Even Cash Flow Non-Executive Board Chairman Resignation

Retrieved on: 
Tuesday, May 10, 2022
Board, Forward-looking statement, EBITDA, Nasdaq, GLOBE, Company, DO, Compensation, CFO, Harbert, Incentive, Shareholder, Proxy, Industry, Exchange, Auditor, Dolphin, U.S. Securities and Exchange Commission, Terminology, CEO, Acquisition, Animal, Whaling, Security (finance), Qumu Corporation

GREENWICH, Conn., May 10, 2022 (GLOBE NEWSWIRE) -- Dolphin Limited Partnership III, L.P.(“Dolphin”) and another entity, combined holding ~670,000 Qumu Corporation (Nasdaq: QUMU) shares or ~3.7% of the outstanding common stock, today announced that, on December 6, 2021, Dolphin submitted a non-binding Proposal #5 for inclusion in Qumu’s proxy statement for its delayed June 2, 2022 annual shareholder’s meeting.

Key Points: 
  • Dolphin requests the Board immediately achieve cash flow break-even, no additional onerous dilutive financings, and the resignation of Neil E. Cox, Non-Executive Chairman of the Board.
  • In March 2013, Dolphin disclosed holding approximately 6.5% of Qumu and the addition of a Dolphin sponsored Director and observer to the Board.
  • Qumu owned its current business, acquired in 2011 for $52 million and Dolphin calculated over $80 million of cash and assets convertible to cash (then approximately $9.25 per share).
  • In July 2015, a Dolphin Director was added to the Board with objectives of eliminating $25 million of costs and cash flow break-even, both accomplished.

Graylog Completes $18 Million Growth Equity Round

Retrieved on: 
Thursday, June 24, 2021
Data management, Security, Technology, Software, Networks, Internet, Graylog, Web log analysis software, Harbert, Piper Sandler Companies, Companies, Service companies, Economy of the United States

Graylog , a global provider of next-generation log management solutions, today announced an $18 million growth equity round led by new investor Harbert Growth Partners and co-investor Piper Sandler Merchant Banking.

Key Points: 
  • Graylog , a global provider of next-generation log management solutions, today announced an $18 million growth equity round led by new investor Harbert Growth Partners and co-investor Piper Sandler Merchant Banking.
  • The investment will fuel the companys growth plans and help further position it as a leader in the log management and analytics market.
  • Graylog is well-positioned to be a long-term winner in the rapidly growing market for log management and analysis solutions, said Brian Carney, General Partner, Harbert Growth Partners.
  • We are thrilled to partner with the Graylog team to leverage the significant opportunity that lies ahead for the company.

Harbert Discovery Fund Responds to Enzo Biochem, Inc.’s Recent Strategic Announcements

Retrieved on: 
Tuesday, March 16, 2021
Harbert, LabCorp

We believe these interested acquirers and others would be willing to pay a significant premium to the current share price.

Key Points: 
  • We believe these interested acquirers and others would be willing to pay a significant premium to the current share price.
  • That coupled with the engagement of former LabCorp Diagnostics CEO Gary Huff, provides Enzo with ties to the most logical strategic acquirers.
  • The recent performance, which is largely driven by COVID-19 also aligns extremely well with a sales process.
  • Harbert Discovery Co-Investment Fund I, LP
    Kenan Lucas, Managing Director and Portfolio Manager of Harbert Discovery Fund GP, LLC and Harbert Discovery Co-Investment Fund I GP, LLC
    THIS STATEMENT CONTAINS OUR CURRENT VIEWS ON THE VALUE OF SECURITIES OF ENZO BIOCHEM, INC. (ENZO).

Harbert Discovery Fund Issues Letter to the Independent Directors of Enzo Biochem, Inc. - February 26, 2021

Retrieved on: 
Friday, February 26, 2021
Harbert

According to a New York Times obituary for Benjamin Greenberg from December 9, 1997, Joshua Rabbani is Elazar Rabbanis son.

Key Points: 
  • According to a New York Times obituary for Benjamin Greenberg from December 9, 1997, Joshua Rabbani is Elazar Rabbanis son.
  • Joshua Rabbani is listed as an inventor on 18 Enzo patents going back to a first filing date of August 24, 2010.
  • We sent four separate emails to the Independent Directors on this topic over the last several weeks and have not received a response.
  • Harbert Discovery Co-Investment Fund I, LP
    Kenan Lucas, Managing Director and Portfolio Manager of Harbert Discovery Fund GP, LLC and Harbert Discovery Co-Investment Fund I GP, LLC
    THIS STATEMENT CONTAINS OUR CURRENT VIEWS ON THE VALUE OF SECURITIES OF ENZO BIOCHEM, INC. (ENZO).

Watercrest Senior Living Group and Harbert Seniors Housing Fund II Announce the Groundbreaking of Watercrest Richmond Assisted Living and Memory Care

Retrieved on: 
Wednesday, January 13, 2021
Health, Harbert, Assisted living

VERO BEACH, Fla., Jan. 13, 2021 /PRNewswire/ --Watercrest Senior Living Group and joint venture partner, Harbert Seniors Housing Fund II, are pleased to announce the groundbreaking of Watercrest Richmond Assisted Living and Memory Care in Richmond, Virginia.

Key Points: 
  • VERO BEACH, Fla., Jan. 13, 2021 /PRNewswire/ --Watercrest Senior Living Group and joint venture partner, Harbert Seniors Housing Fund II, are pleased to announce the groundbreaking of Watercrest Richmond Assisted Living and Memory Care in Richmond, Virginia.
  • Watercrest Richmond will be a signature Watercrest product, offering 76 assisted living and 22 memory care apartments with resort-style service and world-class care.
  • "We are thrilled to announce Watercrest's expansion into Virginia and thankful for our outstanding partnership with Harbert in the development of Watercrest Richmond," says Marc Vorkapich , Principal and CEO of Watercrest Senior Living Group.
  • "Harbert identified Watercrest Senior Living as a best-in-class senior living developer and operator with a commonly aligned vision to develop exemplary senior living communities for our stakeholders," says Brian Landrum , Senior Managing Director of Harbert Management Corporation.

Harbert Discovery Fund Issues Letter to the Independent Directors of Enzo Biochem, Inc.

Retrieved on: 
Monday, January 4, 2021
Harbert, Investment fund

Independent Directors of the Board,

Key Points: 
  • Independent Directors of the Board,
    Earlier today Enzo Biochem Inc. (Enzo or the Company) held its 2020 annual meeting (Annual Meeting).
  • Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively HDF) currently own approximately 11.74% of the outstanding shares of Enzo, making us the Companys largest shareholder.
  • Does the Company have a mechanism for concerned employees to report their concerns directly to the independent directors without a fear of retribution?
  • Harbert Discovery Co-Investment Fund I, LP
    Kenan Lucas, Managing Director and Portfolio Manager of Harbert Discovery Fund GP, LLC and Harbert Discovery Co-Investment Fund I GP, LLC
    THIS STATEMENT CONTAINS OUR CURRENT VIEWS ON THE VALUE OF SECURITIES OF ENZO BIOCHEM, INC. (ENZO).

Harbert Discovery Fund Issues Letter to Mary Tagliaferri and Ian Walters, Current Directors of Enzo Biochem, Inc.

Retrieved on: 
Wednesday, December 30, 2020
Harbert, Investment fund, Fiduciary, Harbert Management Corporation, Raymond J. Harbert

As you know, both ISS and Glass Lewis take pride in providing serious, independent, and unbiased assessments of company corporate governance.

Key Points: 
  • As you know, both ISS and Glass Lewis take pride in providing serious, independent, and unbiased assessments of company corporate governance.
  • We believe you have a fiduciary responsibility to accept his resignation, and we strongly urge you to accept it.
  • Harbert Discovery Co-Investment Fund I, LP
    Kenan Lucas, Managing Director and Portfolio Manager of Harbert Discovery Fund GP, LLC and Harbert Discovery Co-Investment Fund I GP, LLC
    THIS STATEMENT CONTAINS OUR CURRENT VIEWS ON THE VALUE OF SECURITIES OF ENZO BIOCHEM, INC. (ENZO).
  • HMC is an alternative asset management firm with approximately $7.5 billion in regulatory assets under management as of November 30, 2020.

Harbert Discovery Fund Issues Letter to Dov Perlysky, Chairman of Enzo Biochem’s Compensation Committee

Retrieved on: 
Tuesday, December 15, 2020
Harbert, Portfolio manager, Fund

We are writing to express disappointment in you as Chairman of Enzo Biochem, Inc.s (Enzo or the Company) Compensation Committee based on Elazar Rabbani (Rabbani) and Barry Weiners (Weiner) excessive, unjustifiable 2020 compensation.

Key Points: 
  • We are writing to express disappointment in you as Chairman of Enzo Biochem, Inc.s (Enzo or the Company) Compensation Committee based on Elazar Rabbani (Rabbani) and Barry Weiners (Weiner) excessive, unjustifiable 2020 compensation.
  • Harbert Discovery Fund, LP and Harbert Discovery Co-Investment Fund I, LP (collectively HDF) currently own approximately 11.74% of the outstanding shares of Enzo, making us the Companys largest shareholder.
  • Contrary to your statement, Enzos 2020 proxy statement does not disclose any metrics by which you judged managements performance.
  • Harbert Discovery Co-Investment Fund I, LP
    Kenan Lucas, Managing Director and Portfolio Manager of Harbert Discovery Fund GP, LLC and Harbert Discovery Co-Investment Fund I GP, LLC
    THIS STATEMENT CONTAINS OUR CURRENT VIEWS ON THE VALUE OF SECURITIES OF ENZO BIOCHEM, INC. (ENZO).

Harbert Discovery Fund Issues Letter to Enzo Biochem Board of Directors

Retrieved on: 
Wednesday, November 18, 2020
Harbert, Investment fund, Portfolio manager, Finance, Economy, Business, Raymond J. Harbert

It is time for the remaining independent directors to demand Elazars immediate resignation.

Key Points: 
  • It is time for the remaining independent directors to demand Elazars immediate resignation.
  • Investors are left to ponder what independent directors Perlysky and Fischer stand to benefit from Elazars continued entrenchment.
  • Harbert Discovery Co-Investment Fund I, LP
    Kenan Lucas, Managing Director and Portfolio Manager of Harbert Discovery Fund GP, LLC and Harbert Discovery Co-
    Investment Fund I GP, LLC
    THIS STATEMENT CONTAINS OUR CURRENT VIEWS ON THE VALUE OF SECURITIES OF ENZO BIOCHEM, INC. (ENZO).
  • HMC is an alternative asset management firm with approximately $7.4 billion in regulatory assets under management as of October 31, 2020.